Women's attitude towards prenatal screening for red blood cell antibodies, other than RhD

BMC Pregnancy and Childbirth

Volumn 8, Issue , 2008, Pages

  Koelewijn, J M ^a,b,c   Vrijkotte, T G M ^c   de Haas, M ^a,b   van der Schoot, C E ^a,b,c   Bonsel, G J ^c,d  

^a SANQUIN RESEARCH   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROCYTE ANTIBODY; RHESUS ANTIBODY; ALLOANTIBODY; RHO(D) ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANXIETY; ARTICLE; CONTROLLED STUDY; FEMALE; FIRST TRIMESTER PREGNANCY; HEALTH SURVEY; HUMAN; LONGITUDINAL STUDY; MULTIVARIATE ANALYSIS; NETHERLANDS; OBSTETRIC CARE; OUTCOMES RESEARCH; PATIENT ATTITUDE; PERINATAL PERIOD; PREDICTION; PREGNANT WOMAN; PRENATAL PERIOD; PRENATAL SCREENING; SATISFACTION; SCREENING TEST; STATE TRAIT ANXIETY INVENTORY; STRUCTURED QUESTIONNAIRE; UNIVARIATE ANALYSIS; ATTITUDE TO HEALTH; BLOOD; BLOOD GROUP RHESUS SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; ERYTHROCYTE; FOLLOW UP; IMMUNOLOGY; INCIDENCE; MASS SCREENING; METHODOLOGY; MULTICENTER STUDY; PATIENT COMPLIANCE; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL CARE; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR;

ATTITUDE TO HEALTH; ERYTHROCYTES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; ISOANTIBODIES; MASS SCREENING; NETHERLANDS; PATIENT COMPLIANCE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PRENATAL CARE; RH-HR BLOOD-GROUP SYSTEM; RISK FACTORS;

EID: 58049195699     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-8-49     Document Type: Article

References (21)

1. Committee prevention pregnancy immunisation Prevention of pregnancy immunisation The Hague: Dutch Health Council, [Dutch] 1992, 50
2. Health Care Insurance Board Blood testing in pregnancy. Pregnancy immunisation, hepatitis B and lues Health Care Insurance Board. Inspection Public Health [Dutch] 1998
3. Moise KJ Jr Non-anti-D antibodies in red-cell alloimmunization Eur J Obstet Gynecol Reprod Biol 2000, 92(1):75-81 10.1016/ S0301-2115(00)00428-0 10986438
4. Moise KJ Red blood cell alloimmunization in pregnancy Semin Hematol 2005, 42(3):169-178 10.1053/j.seminhematol.2005.04.007 16041667
5. van Kamp IL Klumper FJ Oepkes D Meerman RH Scherjon SA Vandenbussche FP et al. Complications of intrauterine intravascular transfusion for fetal anemia due to maternal red-cell alloimmunization Am J Obstet Gynecol 2005, 192(1):171-177 10.1016/j.ajog.2004.06.063 15672021
6. Koelewijn JM Vrijkotte TG Schoot Van der CE Bonsel GJ de Haas M Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: A population study in the Netherlands Transfusion 2008, 48(5):941-952 10.1111/ j.1537-2995.2007.01625.x 18248570
7. Urbaniak SJ Greiss MA RhD: Haemolytic disease of the fetus and the newborn Blood Rev 2000, 14(1):44-61 10.1054/blre.1999.0123 10805260
8. Wilson JMG Jüngner G Principles and practice of screening for disease Public Health Papers Geneva, World Health Organization 1968, 34
9. Stichting Perinatale Registratie Nederland Perinatal Care in the Netherlands 2004 Utrecht: Stichting Perinatale Registratie Nederland [Dutch] 2007, 92
10. Oepkes D Seaward PG Vandenbussche FP Windrim R Kingdom J Beyene J et al. Doppler ultrasonography versus amniocentesis to predict fetal anemia N Engl J Med 2006, 355(2):156-164 10.1056/NEJMoa052855 16837679
11. Wildschut HI Peters TJ Weiner CP Screening in women's health, with emphasis on fetal Down's syndrome, breast cancer and osteoporosis Hum Reprod Update 2006, 12(5):499-512 10.1093/humupd/dml027 16807275
12. Kerbel D Glazier R Holzapfel S Yeung M Lofsky S Adverse effects of screening for gestational diabetes: A prospective cohort study in Toronto, Canada J Med Screen 1997, 4(3):128-132 9368868
13. Rumbold AR Crowther CA Women's experiences of being screened for gestational diabetes mellitus Aust N Z J Obstet Gynaecol 2002, 42(2):131-137 10.1111/j.0004-8666.2002.00131.x 12069138
14. Fransen MP Essink-Bot ML Oenema A Mackenbach JP Steegers EA Wildschut HI Ethnic differences in determinants of participation and non-participation in prenatal screening for Down syndrome: A theoretical framework Prenat Diagn 2007, 27(10):938-950 10.1002/pd.1805 17597492
15. Wallston KA Wallston BS DeVellis R Development of the multidimensional health locus of control (MHLC) scales Health Education Monographs 2007, 6:160-170
16. Spielberger CD Gorusch RL Lushene LE STAI manual for the state-trait anxiety inventory Consulting Psychologists Press Palo Alto C 1970
17. Spielberger CD State-trait anxiety inventory for adults. Sampler set, manual, test, scoring key Consulting Psychologists Press Pao Alto C 1983
18. Krabbe PF Salomon JA Murray CJ Quantification of health states with rank-based nonmetric multidimensional scaling Med Decis Making 2007, 27(4):395-405 10.1177/0272989X07302131 17761959
19. Balon R Rating scales for anxiety/anxiety disorders Curr Psychiatry Rep 2007, 9(4):271-277 10.1007/s11920-007-0032-8 17880857
20. Rumbold AR Crowther CA Women's experiences of being screened for gestational diabetes mellitus Aust N Z J Obstet Gynaecol 2002, 42(2):131-137 10.1111/j.0004-8666.2002.00131.x 12069138
21. Wijnen H The Kempen study: Aspects of maternal well-being and obstetrical outcome in relation to gestational thyroid function Thesis University of Tilburg, the Netherlands 2005